Skystar Bio-Pharm. Retains CCG Elite for Investor Relations Services

   Date:2007/04/19

Skystar Bio-Pharmaceutical Co., Ltd., a leading bio-pharmaceutical company in the People's Republic of China ("PRC"), announced that it has retained CCG Elite to design and execute its investor relations campaign.

Skystar Bio-Pharmaceutical is one of China's leading manufacturers and distributors of vaccines and medicines for poultry, livestock and domestic pets. The company currently has over 70 products in the market and over 50 new products in development. Skystar Bio-Pharmaceutical has established a strong distribution network with over 500 distribution agents throughout China and has over 200 direct customers. Its products are categorized by four segments: vaccines, veterinary medication, micro-organism, and feed additives.

"Skystar Bio-Pharmaceutical has created a leading market position in the veterinary biopharmaceutical industry. We have a proven track record for growing both revenue and net income. We intend to continue growing our business by expanding our distribution network and targeting higher margin biopharmaceuticals. We look forward to working with CCG Elite in communicating our value proposition to investors as we build our market presence and brand recognition," commented Mr. Weibing Lu, Chairman and Chief Executive Officer of Skystar Bio-Pharmaceutical.

In December 2006, Skystar Bio-Pharmaceutical expanded its production capacity with the opening of its new Good Manufacturing Practice (GMP) certified factory. The company also intends to increase its market penetration by opening four new distribution offices that will cover Zhejiang, Jiangsu, and Fujian and by implementing aggressive advertising campaigns in the local cities and villages.

"China is one of the largest livestock producers in the world and has recently experienced double-digit growth in demand for livestock. As a result, demand for veterinary medication continues to outpace supply," commented Crocker Coulson, President of CCG Elite. "Skystar Bio-Pharmaceutical is an exciting company with strong growth potential," commented Crocker Coulson, President of CCG Elite.

 

Source:佚名

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号